SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 26 filers reported holding SINOVAC BIOTECH LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 68,732 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 68,732 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 68,732 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 68,732 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 68,732 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 68,732 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 68,732 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 68,732 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 68,732 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 68,732 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 68,732 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 68,732 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 68,732 | 0.0% | 0.00% | -100.0% |
| Q1 2020 | $445,000 | 0.0% | 68,732 | 0.0% | 0.00% | – |
| Q4 2019 | $445,000 | 0.0% | 68,732 | 0.0% | 0.00% | – |
| Q3 2019 | $445,000 | 0.0% | 68,732 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $445,000 | 0.0% | 68,732 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $445,000 | -6.7% | 68,732 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $477,000 | -9.8% | 68,732 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $529,000 | +1.1% | 68,732 | -1.9% | 0.00% | 0.0% |
| Q2 2018 | $523,000 | -34.0% | 70,064 | -23.9% | 0.00% | 0.0% |
| Q1 2018 | $793,000 | +62.2% | 92,127 | +48.6% | 0.00% | 0.0% |
| Q4 2017 | $489,000 | +12.2% | 62,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $436,000 | +4.1% | 62,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $419,000 | +18.0% | 62,000 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $355,000 | -7.1% | 62,000 | -4.2% | 0.00% | 0.0% |
| Q4 2016 | $382,000 | 0.0% | 64,700 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $382,000 | -7.1% | 64,700 | -6.6% | 0.00% | 0.0% |
| Q2 2016 | $411,000 | -10.1% | 69,300 | -3.1% | 0.00% | 0.0% |
| Q1 2016 | $457,000 | +5.3% | 71,500 | -5.8% | 0.00% | 0.0% |
| Q4 2015 | $434,000 | +12.4% | 75,900 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $386,000 | -3.0% | 75,900 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $398,000 | +8.4% | 75,900 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $367,000 | 0.0% | 75,900 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $367,000 | +0.3% | 75,900 | -0.1% | 0.00% | 0.0% |
| Q3 2014 | $366,000 | -20.1% | 76,001 | -6.5% | 0.00% | 0.0% |
| Q2 2014 | $458,000 | -56.4% | 81,261 | -48.9% | 0.00% | -50.0% |
| Q1 2014 | $1,050,000 | +117.4% | 158,903 | +109.4% | 0.00% | +100.0% |
| Q4 2013 | $483,000 | +6.4% | 75,900 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $454,000 | +52.3% | 75,900 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $298,000 | – | 75,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,500,000 | 6.32% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.21% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.72% |
| Yorktown Management & Research Co Inc | 74,893 | $485,000 | 0.63% |
| Skandinaviska Enskilda Banken AB (publ) | 40,000 | $259,000 | 0.00% |
| Renaissance Technologies | 2,375,841 | $1,537,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,687 | $11,000 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $55,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $27,000 | 0.00% |